Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Terns Pharmaceuticals, Inc. (TERN) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
-- |
|
$-23.91M |
|
-- |
|
-- |
|
$27.43M |
|
$-27.43M |
|
$3.61M |
|
$-23.82M |
|
$-23.82M |
|
$-23.91M |
|
$-23.91M |
|
$-23.91M |
|
$-23.91M |
|
$-27.43M |
|
$-27.26M |
|
91.47M |
|
91.47M |
|
$-0.26 |
|
$-0.26 |
|
| Balance Sheet Financials | |
$337.75M |
|
$0.08M |
|
$1.57M |
|
$339.31M |
|
$10.94M |
|
-- |
|
$2.34M |
|
$13.27M |
|
$326.04M |
|
$326.04M |
|
$326.04M |
|
87.30M |
|
| Cash Flow Statement Financials | |
$-24.44M |
|
$1.96M |
|
$0.07M |
|
$161.44M |
|
$139.02M |
|
$-22.42M |
|
$3.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
30.89 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-24.44M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.33% |
|
-7.33% |
|
-7.05% |
|
-7.33% |
|
$3.73 |
|
$-0.27 |
|
$-0.27 |
|